Diseases

Diseases

Lundbeck Presents Pipeline Developments for Amlenetug at 2025 International Congress of Parkinson's Disease and Movement Disorders

Lundbeck's pipeline developments for amlenetug, a novel investigational molecule for treating Multiple System Atrophy (MSA), will be presented at the 2025 International Congress of Parkinson's Disease and Movement Disorders in Honolulu, Hawaii. Amlenetug, a human monoclonal antibody, targets pathological aggregations of the protein a-synuclein in the

Diseases

Care Navigation Supports Research Participation in Underrepresented Populations with Alzheimer's Disease and Related Dementias

New research suggests that care navigation can increase research participation among underrepresented populations with Alzheimer's disease and related dementias (ADRD). The study, conducted by researchers at Duke University Medical Center, found that a program designed to address individual medical and nonmedical caregiver and patient needs can support research